Peripheral Nerve block Preoperatively - Nursing Case Study
Pathophysiology
• Primary mechanism: Peripheral nerve blocks work by inhibiting voltage-gated sodium channels in the neuronal cell membrane, which prevents depolarization and subsequent nerve impulse transmission, resulting in localized anesthesia.
• Secondary mechanism: The blockade of nerve conduction affects both sensory and motor fibers, leading to loss of sensation and muscle relaxation in the targeted area, which aids in pain control and surgical accessibility.
• Key complication: Severe complications can include systemic toxicity from local anesthetic absorption, leading to central nervous system symptoms such as seizures or cardiovascular instability, emphasizing the importance of precise dosing and monitoring.
Patient Profile
Demographics:
65-year-old female, retired construction worker
History:
• Key past medical history: Type 2 Diabetes, Hypertension, Chronic Kidney Disease Stage 3, Previous Myocardial Infarction
• Current medications: Metformin, Lisinopril, Metoprolol, Atorvastatin, Aspirin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Severe right leg pain and numbness
• Key symptoms: Persistent tingling sensation, inability to bear weight on right leg, swelling in the lower extremity
• Vital signs: Blood Pressure 180/110 mmHg, Heart Rate 110 bpm, Respiratory Rate 24 breaths per minute, Temperature 100.2°F, Oxygen Saturation 88% on room air
Section 1
As the healthcare team initiates the preoperative assessment for the planned peripheral nerve block, several critical findings emerge that will shape the subsequent care plan. The patient's vital signs remain alarming, with blood pressure consistently elevated at 182/115 mmHg, a heart rate of 112 bpm, and respiratory rate increasing to 26 breaths per minute. Despite supplemental oxygen, her oxygen saturation is struggling to stabilize, fluctuating between 85% and 88%. Notably, the patient's blood glucose level is revealed to be 245 mg/dL, suggesting suboptimal glycemic control, likely exacerbated by physiological stress and infection, given her elevated temperature of 100.8°F.
Further complicating the clinical picture, new lab results indicate a worsening renal function, with the glomerular filtration rate (GFR) declining to 38 mL/min/1.73m², compared to 45 mL/min/1.73m² from her last check three months ago. Serum potassium levels are found to be elevated at 5.8 mmol/L, raising concerns about potential hyperkalemia, which could predispose her to cardiac dysrhythmias. Given her history of myocardial infarction, the decision to proceed with the nerve block must be weighed against the risk of cardiovascular complications, necessitating careful consideration of anesthetic choice and dosage.
The patient's clinical status raises significant red flags for the perioperative team. The elevated blood pressure and heart rate, coupled with reduced oxygen saturation and hyperkalemia, require immediate intervention to stabilize her condition prior to administering the nerve block. The team must engage in advanced critical thinking to balance the management of her acute symptoms with the need for surgical intervention, considering the potential for systemic toxicity from local anesthetics in the context of her compromised renal clearance. These developments prompt a multidisciplinary discussion, involving cardiology, nephrology, and anesthesiology, to formulate a comprehensive plan that mitigates risks and optimizes patient safety.
Section 2
As the healthcare team delves deeper into the initial assessment findings, they uncover additional complexities that challenge their clinical judgment. The patient's past medical history reveals poorly controlled hypertension and type 2 diabetes, which are likely contributing to her current destabilized state. Furthermore, the presence of peripheral edema and jugular venous distension suggests the possibility of evolving congestive heart failure, complicating the management of her elevated blood pressure and heart rate. Auscultation of the lungs reveals bilateral crackles at the bases, raising concerns about fluid overload and the risk of pulmonary edema, which could further compromise her already precarious oxygenation status.
To further elucidate the patient's condition, a 12-lead electrocardiogram is performed, revealing sinus tachycardia with occasional premature ventricular contractions, likely secondary to her electrolyte imbalance and underlying cardiac history. An echocardiogram is ordered to assess cardiac function, with initial findings indicating a reduced ejection fraction of 40%, revealing compromised myocardial performance. This necessitates an adjustment in the patient's medication regimen, with consideration for diuretics to manage fluid overload and beta-blockers to control her heart rate and mitigate cardiac stress.
Faced with these findings, the multidisciplinary team must rapidly devise a tailored intervention plan. The nephrologist suggests cautious diuresis to address the fluid status without worsening renal function, while the cardiologist emphasizes the need for strict blood pressure control using intravenous antihypertensives. The anesthesiologist carefully evaluates the choice of local anesthetic for the nerve block, opting for agents with minimal systemic absorption to reduce the risk of toxicity. The team's strategic approach aims to stabilize the patient's condition sufficiently to proceed with the nerve block, all while vigilantly monitoring for the emergence of new complications, such as electrolyte imbalances or arrhythmias, that could derail the perioperative plan.
Section 3
As the team implements the intervention plan, the patient's condition initially shows slight improvement, with a reduction in peripheral edema and a more stable heart rate following the cautious administration of diuretics and beta-blockers. However, during routine monitoring, the patient's blood pressure becomes erratic, with readings fluctuating between 180/100 mmHg and 130/80 mmHg. This instability prompts further investigation and reveals that the patient's renal function is deteriorating, indicated by a rise in creatinine levels from 1.4 mg/dL to 2.0 mg/dL and a decrease in estimated glomerular filtration rate (eGFR), now at 45 mL/min/1.73 m².
Compounded by this change, the patient begins to exhibit signs of worsening respiratory function, with increased work of breathing and oxygen saturation dropping to 88% on room air. Repeat auscultation identifies an expansion of crackles throughout the lung fields, suggesting progression towards pulmonary edema despite diuretic therapy. The team decides to initiate supplemental oxygen and start low-dose intravenous nitroglycerin to help alleviate both the pulmonary congestion and the persistent hypertension, while carefully balancing the risk of further renal compromise.
As these complications unfold, the multidisciplinary team reassesses the feasibility of proceeding with the peripheral nerve block. The anesthesiologist expresses concern over the potential exacerbation of the patient's hemodynamic instability during the procedure. A critical decision is made to delay the nerve block until the patient's respiratory status and renal function show signs of improvement. Meanwhile, efforts are concentrated on achieving optimal fluid balance and electrolyte management, with close monitoring for any emergent arrhythmias. The situation demands vigilant observation and dynamic adjustment of the treatment plan, highlighting the need for advanced clinical reasoning in navigating the complexities of the patient's evolving condition.
Section 4
As the team closely monitors the patient, a concerning change in status emerges. Despite supplemental oxygen and intravenous nitroglycerin, the patient's oxygen saturation continues to struggle, now fluctuating between 85% and 90% even on 2 liters of oxygen via nasal cannula. The respiratory rate has increased to 28 breaths per minute, with noticeable use of accessory muscles. These indicators suggest that the pulmonary edema is more resistant to treatment than initially anticipated. Additionally, the blood pressure remains labile, with intermittent systolic spikes over 170 mmHg, which further complicates respiratory efforts and increases myocardial oxygen demand. The diuretic therapy is adjusted to include a combination of loop and thiazide diuretics to enhance diuresis, but the anticipated response is not immediate.
In parallel, new diagnostic results reveal an alarming trend in renal function. The patient's creatinine continues to rise, now reaching 2.3 mg/dL, and the eGFR has dropped further to 38 mL/min/1.73 m², indicating acute kidney injury (AKI) likely secondary to both the hemodynamic instability and aggressive diuresis. The electrolyte panel shows a drop in serum potassium to 3.0 mEq/L, necessitating careful replacement to prevent arrhythmias, especially given the patient's labile cardiovascular status. A decision is made to consult nephrology for potential renal support options, including the possibility of initiating renal replacement therapy if the AKI progresses.
Given the complex interplay of cardiovascular, respiratory, and renal challenges, the team convenes to reassess the overall management strategy. The current priority is to stabilize the patient's hemodynamics and respiratory function while mitigating further renal damage. This involves a delicate balance of fluid management, electrolyte correction, and cautious titration of medications. The evolving situation underscores the need for continuous re-evaluation and adaptation of the treatment plan, demanding high-level critical thinking to navigate the intricate interdependencies affecting the patient's health trajectory.
Section 5
As the team continues to navigate the complexities of the patient's condition, a new complication arises that demands immediate attention. The patient begins to experience episodes of acute confusion and agitation, raising concerns about possible hypoxemia-induced encephalopathy or an evolving metabolic disturbance. Neurological evaluation reveals subtle but concerning signs, including slight hand tremors and asterixis, which suggest the possibility of hepatic encephalopathy or uremic encephalopathy due to the worsening renal function. Given the patient's recent lab results showing elevated ammonia levels and a BUN of 80 mg/dL, the team suspects that the renal impairment is significantly contributing to the neurological symptoms.
In response to this alarming development, the team prioritizes the correction of metabolic abnormalities. The patient's serum bicarbonate has dropped to 16 mEq/L, indicating metabolic acidosis, which could be exacerbating both the respiratory and neurological symptoms. Sodium bicarbonate therapy is initiated cautiously, with frequent monitoring of arterial blood gases to prevent overcorrection. Additionally, the nephrology team recommends initiating continuous renal replacement therapy (CRRT) to address the acute kidney injury and facilitate the removal of accumulated toxins.
This multifaceted approach requires meticulous coordination among the critical care team, with constant reassessment of the patient's response to interventions. The situation underscores the delicate balance needed to manage the interconnected systems at play, demanding rigorous clinical reasoning to adjust the treatment plan dynamically. As the patient remains in a critical state, the team recognizes the need for vigilance in monitoring for further complications, such as arrhythmias from electrolyte imbalances or worsening hemodynamic instability, all while providing supportive care to optimize the patient's recovery trajectory.